From Our 2010 Archives
Inactivating Gene May Cut Breast Cancer Risk
Latest Cancer News
THURSDAY, April 1 (HealthDay News) -- A genetic mutation in the gene known as BRCA1 greatly boosts the risk that a woman will develop breast cancer. But now, researchers report that they've been able to lower the risk of cancer in mice with that gene by deactivating another gene.
Women with the mutation have as much as an 85% greater lifetime risk for developing breast cancer than other women. They also have up to a 40% greater chance of developing ovarian cancer.
Lead investigator Andre Nussenzweig and his colleagues from the U.S. National Cancer Institute found that inactivation of a gene known as 53BP1 lowered the risk for breast tumors in mice. The mice had a defective BRCA1 gene, which boosted their chances of developing breast cancer just as it does in humans.
The researchers also found that tumors connected to BRCA1 mutations might be able to fight off chemotherapy better than other kinds of tumors. But, they noted, it's possible that scientists will be able to develop drugs to combat this effect.
The study findings were released online April 1 in advance of publication in the April 16 print issue of the journal Cell.
-- Randy Dotinga
Copyright © 2010 HealthDay. All rights reserved.
SOURCE: U.S. National Cancer Institute, news release, April 1, 2010
- Allergic Skin Disorders
- Bacterial Skin Diseases
- Bites and Infestations
- Diseases of Pigment
- Fungal Skin Diseases
- Medical Anatomy and Illustrations
- Noncancerous, Precancerous & Cancerous Tumors
- Oral Health Conditions
- Papules, Scales, Plaques and Eruptions
- Scalp, Hair and Nails
- Sexually Transmitted Diseases (STDs)
- Vascular, Lymphatic and Systemic Conditions
- Viral Skin Diseases
- Additional Skin Conditions